Zhou Yu, Lu Jiao, Liu Lin, Wang Hao-Wei
School of Sports Sciences, Nanjing Normal University, Nanjing, Jiangsu, People's Republic of China.
School of Sport and Health, Nanjing Sport Institute, Nanjing, Jiangsu, People's Republic of China.
J Pain Res. 2023 Jan 28;16:245-256. doi: 10.2147/JPR.S390386. eCollection 2023.
To systematically evaluate the effect of exercise rehabilitation as an adjuvant to clinical treatment for myofascial trigger points (MTrPs).
ESBCO, PubMed, Science Direct, Web of Science, China Knowledge Network (CNKI), and Wanfang databases were comprehensively searched from database inception date through July 2022. Randomized controlled trials comparing MTrPs treatments that included exercise rehabilitation with a single clinical treatment. Two researchers independently screened articles using inclusion/exclusion criteria, scored methodologic quality, and extracted data including patient demographics, interventions, and outcomes.
We included 14 RCTs (N = 734). Results showed short-term (mean difference [MD], -2.25; 95% confidence interval [CI], -4.08 to -0.41; Z = 2.40; P = 0.02) and long-term (MD = -0.47; 95% CI: -0.80 to -0.17; Z = 3.05; P = 0.02) adjuvant exercise rehabilitation treatments were superior in reducing musculoskeletal pain intensity to single clinical treatment in controls, but long-term versus short-term effectiveness was not significantly different. The exercise rehabilitation group more effectively increased the range of motion (ROM) (standardized mean difference [SMD], 1.04; 95% CI: 0.32 to 1.77; Z = 2.84; P = 0.005) and decreased dysfunction (SMD = -0.93; 95% CI: -1.82 to -0.05; Z = 2.06; P = 0.04) than controls; no significant difference was observed in the pressure pain threshold (PPT) between two groups.
Exercise rehabilitation as an adjuvant to clinical treatment for MTrPs was moderately effective in relieving pain intensity, increasing ROM, and improving dysfunction versus single clinical intervention. These findings must be validated by larger, higher-quality studies.
系统评价运动康复作为肌筋膜触发点(MTrP)临床治疗辅助手段的效果。
全面检索了ESBCO、PubMed、Science Direct、Web of Science、中国知网(CNKI)和万方数据库,检索时间从建库至2022年7月。纳入比较包含运动康复的MTrP治疗与单一临床治疗的随机对照试验。两名研究人员独立使用纳入/排除标准筛选文章,对方法学质量进行评分,并提取包括患者人口统计学、干预措施和结局等数据。
我们纳入了14项随机对照试验(N = 734)。结果显示,辅助运动康复治疗在短期(平均差[MD],-2.25;95%置信区间[CI],-4.08至-0.41;Z = 2.40;P = 0.02)和长期(MD = -0.47;95% CI:-0.80至-0.17;Z = 3.05;P = 0.02)在减轻肌肉骨骼疼痛强度方面优于对照组的单一临床治疗,但长期与短期疗效无显著差异。运动康复组比对照组更有效地增加了关节活动范围(ROM)(标准化平均差[SMD],1.04;95% CI:0.32至1.77;Z = 2.84;P = 0.005)并减少了功能障碍(SMD = -0.93;95% CI:-1.82至-0.05;Z = 2.06;P = 0.04);两组之间的压痛阈值(PPT)无显著差异。
与单一临床干预相比,运动康复作为MTrP临床治疗的辅助手段在缓解疼痛强度、增加ROM和改善功能障碍方面有中度效果。这些发现必须通过更大规模、更高质量的研究来验证。